21 September 2021
It can be challenging to find a suitable commercial ELISA to monitor the process-related impurities in cell and gene therapies.
E.g., due to the use of a novel cell line because there are impurities from multiple organisms.
On October 5, Ejvind Mortz shows how Mass spectrometry (LC-MS) provides unrivaled HCP quantification and high reproducibility of each protein impurity – down to low ppm levels.